Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Politics

RFK Jr cancels $500 million in mRNA research, HHS to prioritize ‘safer’ vaccine alternatives

by August 5, 2025
August 5, 2025
RFK Jr cancels $500 million in mRNA research, HHS to prioritize ‘safer’ vaccine alternatives

A total of 22 mRNA vaccine development contracts totaling roughly $500 million have been canceled, the Department of Health and Human Services (HHS) announced Tuesday.

The mRNA investments were part of the government’s Biomedical Advanced Research and Development Authority (BARDA), a division of HHS that drives some of the country’s most advanced scientific research, such as the development of vaccines, drugs and other tools to fight national health threats. The termination of the 22 BARDA contracts follows a several-weeks-long internal review to determine a path forward when it comes to these investments.

‘We reviewed the science, listened to the experts, and acted,’ HHS Secretary Robert F. Kennedy Jr. said Tuesday. ‘BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu. We’re shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate.’

In a short video explaining the move, Kennedy said the benefits simply do not outweigh the risks associated with mRNA vaccines. 

Kennedy went on to point out that not only do mRNA vaccines – as shown during the COVID-19 pandemic – not perform well against viruses that infect the upper respiratory tract, but they also do not defend against mutations of the viruses they are intended to go after.

‘This dynamic drives a phenomena called anogenic shift, meaning that the vaccine paradoxically encourages new mutations and can actually prolong pandemics as the virus constantly mutates to escape the protective effects of the vaccine,’ Kennedy said in the video.

For example, the HHS secretary pointed to the omicron variant of the COVID-19 virus, which infected many millions, including those who had been vaccinated against COVID. 

‘A single mutation can make mRNA vaccines ineffective,’ Kebbedy added, noting that the same risks also apply to the flu virus. 

The move to cancel the mRNA contracts under BARDA will not entirely cancel all mRNA vaccine research done by the government, a source familiar with the move indicated. In addition to allowing some final-stage contracts to run their course to completion in an effort to preserve prior taxpayer investments, ongoing mRNA research at the National Institutes of Health (NIH) will not be impacted by this latest move. 

Meanwhile, in lieu of the terminated mRNA research and investments at BARDA, HHS will focus on ‘safer, broader vaccine strategies,’ Kennedy indicated.

‘To replace the troubled mRNA programs, we’re prioritizing the development of safer, broader vaccine strategies like whole virus vaccines and novel platforms that don’t collapse when viruses mutate,’ Kennedy said in his video explanation about the terminated mRNA investments.

During the video, Kennedy reiterated his support for ‘safe, effective vaccines’ for any American who wants them.

‘That’s why we’re moving beyond the limitations of mRNA for respiratory viruses and investing in better solutions.’

This post appeared first on FOX NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Senate GOP ready to go nuclear after Schumer’s ‘political extortion’ of nominees
next post
Marjorie Taylor Greene urges Trump to commute George Santos’ federal prison sentence: ‘Far worse offenses’

You may also like

Ex-Clinton official applauds Trump’s ‘courageous’ Iran call, doubts...

June 23, 2025

Top Senate Armed Services Republican says Trump OMB’s...

May 2, 2025

Jamie Dimon says Trump ‘wasn’t wrong’ about critical...

January 18, 2024

Steve Bannon: “McCarthy’s Already Committed to MTG That...

November 21, 2022

VoterGA Releases Evidence of 20,000 Votes Being Removed...

December 2, 2022

Republican military vets in Congress are on a...

December 11, 2024

House launches poll watcher program amid GOP-wide push...

September 10, 2024

MIDTERM ELECTION TODAY! Revenge for the Political Persecution...

November 8, 2022

Blackburn, Hagerty press ICE director for answers on...

December 21, 2022

Days from partial government shutdown deadline, here’s where...

March 10, 2025

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Americans embrace Aldi as German discounter becomes fastest-growing supermarket in US

      August 26, 2025
    • Food inflation hits 18-month high as chocolate, butter and egg prices surge

      August 26, 2025
    • Poll finds MPs back electricity tax cuts to boost heat pump adoption

      August 26, 2025
    • Business secretary to meet JCB chief over US tariff chaos

      August 26, 2025
    • Starling Bank makes first acquisition in four years with Ember fintech deal

      August 26, 2025
    • Trump battles John Bolton, Chris Christie and threatens to pull funds from Wes Moore’s Maryland

      August 26, 2025

    Categories

    • Business (8,884)
    • Investing (2,239)
    • Politics (16,488)
    • Stocks (3,228)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved